Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126094931 | 12609493 | 1 | I | 20150531 | 20160727 | 20160801 | 20160801 | EXP | IT-ROCHE-1804479 | ROCHE | 85.39 | YR | M | Y | 0.00000 | 20160801 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126094931 | 12609493 | 1 | PS | RIVOTRIL | CLONAZEPAM | 1 | Oral | '2.5 MG/ML ORAL DROPS, SOLUTION' | U | 17533 | 12 | DF | QD | ||||||
| 126094931 | 12609493 | 2 | I | QUETIAPINE. | QUETIAPINE | 1 | Oral | '25 MG FILM-COATED TABLETS'PERIOD: 3 MONTHS | Y | 0 | 2 | DF | FILM-COATED TABLET | QD | |||||
| 126094931 | 12609493 | 3 | SS | TRITTICO | TRAZODONE HYDROCHLORIDE | 1 | Oral | '25 MG/ML ORAL DROPS, SOLUTION' | Y | 0 | 15 | DF | QD | ||||||
| 126094931 | 12609493 | 4 | SS | DEPAKIN | VALPROATE SODIUM | 1 | Oral | '500 MG GASTRO-RESISTANT TABLETS' 40 TABLETS | U | 0 | 2 | DF | QD | ||||||
| 126094931 | 12609493 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | PERIOD: 3 YEARS | 0 | 500 | MG | TABLET | |||||||
| 126094931 | 12609493 | 6 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 | 2 | G | |||||||||
| 126094931 | 12609493 | 7 | C | LACTULOSE. | LACTULOSE | 1 | Oral | PERIOD: 1 YEAR | 0 | 60 | ML | ||||||||
| 126094931 | 12609493 | 8 | C | PANTORC | PANTOPRAZOLE SODIUM | 1 | Oral | 14 GASTRO-RESISTANT TABLETS ,PERIOD:3 YEARS | 0 | 20 | MG | ||||||||
| 126094931 | 12609493 | 9 | C | TENORMIN | ATENOLOL | 1 | Oral | '100 MG TABLETS' 42 TABLETS,PERIOD: 2 YEARS | 0 | 25 | MG | TABLET | |||||||
| 126094931 | 12609493 | 10 | C | LACIREX | LACIDIPINE | 1 | Oral | '4 MG FILM-COATED TABLETS'PERIOD:3 YEARS | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 126094931 | 12609493 | 11 | C | CARDIOASPIRIN | ASPIRIN | 1 | Unknown | '100 MG GASTRO-RESISTANT TABS PERIOD: 3 YEARS | 0 | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126094931 | 12609493 | 1 | Abnormal behaviour |
| 126094931 | 12609493 | 2 | Abnormal behaviour |
| 126094931 | 12609493 | 3 | Cognitive disorder |
| 126094931 | 12609493 | 4 | Cognitive disorder |
| 126094931 | 12609493 | 5 | Diabetes mellitus |
| 126094931 | 12609493 | 6 | Procedural pain |
| 126094931 | 12609493 | 8 | Gastritis prophylaxis |
| 126094931 | 12609493 | 9 | Cardiac disorder |
| 126094931 | 12609493 | 10 | Hypertension |
| 126094931 | 12609493 | 11 | Platelet aggregation inhibition |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126094931 | 12609493 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126094931 | 12609493 | Drug interaction | |
| 126094931 | 12609493 | Sopor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126094931 | 12609493 | 1 | 20150407 | 20150531 | 0 | |
| 126094931 | 12609493 | 3 | 20150410 | 20150531 | 0 | |
| 126094931 | 12609493 | 6 | 20150407 | 20150531 | 0 |